Redpin Therapeutics
New York, US · Founded 2017 · Delaware corporation · 2 known investors
Find your way into Redpin Therapeutics
Founders & leadership
EH
Elma HawkinsNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$9.3M disclosed across 2 rounds · 2018–2020
▶$7.8MraisedMar 2020 · 8 investors · BiotechnologyRule 506(b)
▶$7.8MraisedMar 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elma HawkinsExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $7.8M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.5MraisedMar 2018 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elma HawkinsExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Redpin Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Redpin Therapeutics's investors?
- Redpin Therapeutics's investors include 4BIO Capital, Takeda Ventures.
- How much funding has Redpin Therapeutics raised?
- Redpin Therapeutics has disclosed $9.3M raised across 2 rounds.
- Where is Redpin Therapeutics headquartered?
- Redpin Therapeutics is headquartered in New York, US.